Available IQVIA Data - IQVIA
`
`iqvia.com/insights/the-iqvia-institute/available-iqvia-data
`
`U.S. National Data
`
`National Sales Perspectives (NSP): Measures dollar and unit sales for pharmaceutical products across multiple distribution channels, including retail, mail, and non-retail. Data is collected from a
`panel of wholesalers, distributors and pharmaceutical manufacturers representing 90% of the pharmaceutical market and projected to a national total.
`National Prescription Audit (NPA): The industry standard source for national pharmaceutical prescription activity, NPA measures demand in terms of dispensed prescriptions to consumers across
`three unique pharmacy channels: retail, mail service, and long-term care. IQVIA collects new and refilled prescription data daily from sample pharmacies covering 93% of outpatient prescription activity,
`and projects this information to create a national estimate for all products, therapeutic classes and manufacturers.
`Xponent: Provides detailed prescriber level prescription information for the U.S., including dispensed drug prescription information from retail pharmacies (chain, mass merchandisers, independent,
`and food stores), mail service pharmacies, and long-term care facilities. It covers 93% of the retail channel and up to 77% coverage in the mail and LTC channels using a customized and patented
`projection methodology to generate accurate market estimates at a state, zip code or individual prescriber level.
`National Disease and Therapeutic Index (NDTI): A compilation of patterns and treatment of disease during patient encounters with office-based physicians, NDTI data includes prescriber,
`patient, product, and diagnosis variables with up to 72 months of history. Information is collected from a statistically representative sample of prescribers and projected to create a national estimate.
`Frequently used in the analysis of drug regimens, on or off-label prescribing, patient/physician characteristics and Rx/Sales allocation.
`ChannelDynamics: This data captures sales force detailing across multiple channels, including office and hospital contacts, sampling, and professional journal advertising. Data are collected though
`methodologies unique to each channel and projected to a national estimate with up to 72 months of history.
`
`Global Data
`
`MIDAS: A unique platform for assessing worldwide healthcare markets, MIDAS integrates IQVIA’s national audits into a globally consistent view of the pharmaceutical market, tracking virtually every
`product in 693 therapeutic classes and provides estimated product volumes, trends and market share through retail and non-retail channels across 77 countries. MIDAS data is updated monthly and
`retains 12 years of history.
`
`Real-World Data
`
`Formulary Impact Analyzer (FIA): FIA provides key insights into the volume of paid, rejected and reversed prescription claims. Tracking the adjudication between pharmacy, payer, and patient at
`the point of sale, lifecycle claims are collected from retail, mail and long-term care pharmacies as well as switch clearinghouses with historical coverage beginning with 2013 and increasing over time.
`Longitudinal Prescription Claims (LRx): IQVIA receives nearly 4 billion prescription claims per year, with history from January 2006 and coverage for more than 90% of retail channel, 60–85% of
`mail service, and 75– 80% of long-term care. Longitudinal data derives from electronic data received from pharmacies, payers, software providers, and transactional clearinghouses.
`Medical and Institutional Claims (Dx and Hx): Dx and Hx include unadjudicated office and institutional medical claims data covering approximately 191 million patients with history building over
`time from 2006. Office claims include patient level diagnosis, procedures, and in-office treatments for visits to U.S. office-based professionals, ambulatory and general healthcare sites. Institutional claims
`data include claims generated for work performed by hospitals, skilled nursing facilities, and other institutions for outpatient and inpatient procedures and services.
`Ambulatory EMR (A-EMR): IQVIA collects EMR data to connect patient vitals, health behaviors, and risk factors to diagnosis and treatment, to understand the impact lab values have on the course of
`treatment, and to develop insights based on provider treatment decisions and written Rx information (compared to dispensed Rx). Detailed clinical data are collected from physician practices, covering
`more than 71 million patients and 100,000 physicians.
`Oncology EMR (O-EMR): IQVIA collects EMR data from oncology practices and hospitals to connect diagnoses, clinical staging, diagnostics, vitals, and treatments to understand the patient journey by
`line of therapy for specific sub-types of cancers. Information is available starting in 2012 and covering more than 1.2 million patients and can be linked to other IQVIA real-world data assets.
`Remittance Data: IQVIA collects remittance data through 835 claims to gain insight into the payment information for office-based drugs and procedures. More than 1.3 billion claims have been
`captured starting in 2012 and include variables relevant to the buy and bill market such as denial reasons, payment adjustments, claim status, procedure codes, and physician demographics.
`Charge Data Master (CDM): CDM information is collected from a panel of up to 400 non-federal hospitals and provides unique insights into what happens and how patients are being treated during
`hospital visits. Tracking patients of all pay types with history beginning with 2009, CDM includes information on procedure or diagnosis codes, deidentified patient demographics, location of care, length
`of stay, and related hospital or care information.
`Pharmetrics Plus for Academics: A closed database of adjudicated medical and pharmacy claims covering more than 107 million unique enrollees since 2006, data contributors are largely
`commercial health plans and are representative of the commercially insured population for patients under 65 years of age.
`
`Healthcare Organization and Provider Data
`
`OneKey: Comprehensive data on more than 9 million healthcare professionals and 700,000 healthcare organizations and their affiliations in the U.S. using a three-tiered class of trade system to arrange
`organizational data resulting in approximately 150 distinct classifications. Professional demographics include affiliation information and attributes such as specialty, professional designation, and NPI,
`while organizational information allows for understanding corporate relationships and integrated healthcare delivery across class of trade categories with details such as 340B or ACO status. Data may be
`linked to other IQVIA assets through identifiers such as NPI.
`
`
`
`
`Exhibit 2207
`Page 01 of 01
`
`